Home › Breast Cancer › NCT04799535

Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* AIM 1: Patient volunteers, ages \>= 18 with suspicious breast masses scheduled for breast biopsy, or at least two weeks or more after breast biopsy
* AIM 2: Patient volunteers, ages \>= 18 who have biopsy proven breast cancer and are going under neoadjuvant chemotherapy and/or endocrine therapy had their baseline MRI and/or ultrasound

Exclusion Criteria:

* Patients with breast implants or any condition that does not allow proper use of ultrasound (US)

About the study

This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and may help measure a patient's response to earlier treatment. The purpose of this research is to test the effectiveness of a new investigational breast ultrasound method to detect an abnormality in the breast, and assess response to breast cancer treatment.

What is being tested

• Ultrasound (procedure)

Sponsor: Mayo Clinic · Participants: 550 · Started: Sep 1, 2019

Contact the study team

Official record on ClinicalTrials.gov — NCT04799535

Locations in the U.S.

Conditions

• Breast Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.